Nextgen Biomed Balance Sheet Health

Financial Health criteria checks 1/6

Nextgen Biomed has a total shareholder equity of ₪-2.1M and total debt of ₪0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ₪822.0K and ₪2.9M respectively.

Key information

0%

Debt to equity ratio

₪0

Debt

Interest coverage ration/a
Cash₪210.00k
Equity-₪2.06m
Total liabilities₪2.88m
Total assets₪822.00k

Recent financial health updates

Recent updates

We Think Nextgen Biomed (TLV:NXGN) Can Afford To Drive Business Growth

Aug 22
We Think Nextgen Biomed (TLV:NXGN) Can Afford To Drive Business Growth

Here's Why We're Not Too Worried About Nextgen Biomed's (TLV:NXGN) Cash Burn Situation

May 02
Here's Why We're Not Too Worried About Nextgen Biomed's (TLV:NXGN) Cash Burn Situation

We're Hopeful That Nextgen Biomed (TLV:NXGN) Will Use Its Cash Wisely

Jan 13
We're Hopeful That Nextgen Biomed (TLV:NXGN) Will Use Its Cash Wisely

Financial Position Analysis

Short Term Liabilities: NXGN has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: NXGN has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: NXGN is debt free.

Reducing Debt: NXGN's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: NXGN has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: NXGN has less than a year of cash runway if free cash flow continues to reduce at historical rates of 21.9% each year


Discover healthy companies